Richard Holbrooke and Laurie Garrett are Full of Sh*t
Update: 6 September 2008
An Important Note About This Blog Entry
The short essay below was originally written as a Letter to the Editor of the Washington Post, because I believed that it was very important to publicly correct the numerous errors and misperceptions contained in the Holbrooke / Garrett editorial.
When the Washington Post did not publish the letter, I sent it to a number people and urgently asked them if they would be so kind as to put forward the ideas contained in the letter, given the important international humanitarian interest in reforming the GISN.
I was therefore very grateful when Ambassador Wibisono of Indonesia adapted the essay below and was able to have it published in the Jakarta Post on my behalf. An utmost priority in the debate over influenza virus sharing is widely circulating the powerful arguments for changing the current system, therefore, I again thank Ambassador Wibisono for his willingness to carry this message to a broader public.
EH
------
... and it's time for America to wake up to that fact.
In their badly informed Washington Post op-ed "'Sovereignty' That Risks Global Health" (10 August), Richard Holbrooke and Laurie Garrett make a number of factual mistakes and misleading statements, some of which I will enumerate here.
The existing World Health Organization (WHO) system of
sharing influenza viruses, called the Global Influenza Surveillance
Network, is radically unjust in that it takes resources from developing
countries and provides little in return, and leaves us all more
vulnerable to an influenza pandemic. Indonesia and other countries that
have taken the initiative to reform the WHO system are taking a
laudable and overdue step to improve public health for all.
There is no constituency seeking to create "viral sovereignty". De
facto, such sovereignty already exists in international law.
Inexplicably, the authors mislead by simply ignoring that fact and, in
particular, 20 years of development of the Convention on Biological
Diversity which, among other international instruments, recognizes
national sovereignty over genetic resources, including microbes.
Viruses are, unequivocally, genetic resources subject to national
sovereignty, whether Holbrooke and Garrett want to admit it or not.
Holbrooke and Garrett claim that it is "ludicrous" to apply
sovereignty to genetic resources that easily cross borders. Their
position belies ignorance of both biodiversity and related law and
policy. As any farmer, biologist, or duck hunter can tell you, most
genetic resources cross borders: birds, plants, insects, microbes,
crops, and practically everything else made of DNA (or, as in the case
of flu, RNA). This simple biological truth has not stopped sovereignty
or international cooperation in biodiversity use and protection.
Transboundary biodiversity issues have been discussed and addressed for
over two decades by the UN. Holbrooke and Garrett have no apparently
clue about this, otherwise they would not have made such an off-base
assertion.
They further state that "The WHO has elicited pledges from the
world's major drug companies not to exploit international repositories
of genetic data for commercial benefit". Such pledges, even if they
existed in the form claimed, are contradicted by fact. First of all, a
number of companies have lodged US and international patent claims over
hundreds of H5N1 genetic sequences - resources that were freely given
to WHO by Indonesia and other countries. These resources come from the
gene repositories.
Secondly, major pharmaceutical companies have advanced clinical
trials underway utilizing Indonesian, Vietnamese, and other viruses in
vaccines. One vaccine using a Vietnamese strain is licensed. The
companies intend to profit from sales of these vaccines, and Indonesia
(and other countries) will receive nothing of the proceeds. The fact of
the matter is that industry - large and small - massively benefits from
resources of the WHO system, and no commeasurate benefit accrues to
Indonesia and other countries who, ironically, are facing the gravest
immediate threat from H5N1.
Further, contrary to Holbrooke and Garrett's erroneous suggestion,
the revised International Health Regulations do not require viruses to
be sent to WHO, and Indonesia has not defied them. The revised
regulations mandate sharing of information on disease outbreaks of
international importance, and such information continues to be shared.
The authors further - and unaccountably - allege that Indonesia has
violated "a host of other WHO agreements". What agreements? I have
participated in the WHO negotiations on influenza virus sharing, where
I have not seen either Holbrooke or Garrett, and I am unaware of any
such allegations.
In reality, Indonesia has repeatedly offered to provide more
viruses to WHO. Neither Indonesia, nor its Health Minister, are
intrinsically opposed to providing viruses. Rather, the stumbling block
is an unwillingness of some countries to implement a just Material
Transfer Agreement (MTA) to define the rights of parties when viruses
are transferred.
The underlying proposition that Garrett and Holbrooke rail against
in their callous editorial is that Indonesia and other countries are
asking for a reasonable MTA for influenza viruses - one that doesn't
rob them - and for an unbiased WHO. The hypocrisy of the US and some
other countries is especially palpable when one looks at the typical
agreements signed by US institutions for transfer of viruses between
themselves. Those agreements are far more restrictive than anything
that Indonesia or its allies have proposed for sharing their viruses.
The move to reform the WHO Global Influenza Surveillance Network is neither
self-destructive nor anti-Western. Holbrooke and Garrett's lashing
out against Indonesia is uninformed about the pertinent policy and law
related to genes and sovereignty, and callous toward the concerns of
developing countries trying to better protect their own citizens from a
pandemic. In their blindness to the obvious injustices of the WHO
system, Garrett and Holbrooke recklessly dismiss a very important, and
potentially very positive - but delicate - negotiation underway to make
the multilateral system more fair and equitable.
It's time for the US and its allies to stop hurling abuse at
Indonesia and to acknowledge the need to reform the virus sharing
system so that developing countries receive tangible benefits for their
participation. Indonesia and other developing countries have put
concrete and detailed proposals on the table for negotiation in Geneva.
The real danger to public health is not sovereignty that is already a
reality; but that these proposals are not discussed and implemented,
leaving us with a dysfunctional global influenza surveillance system.
Information and Links
Join the fray by commenting, tracking what others have to say, or linking to it from your blog.
Comments
H5N1 and reporters
lorac | 18/08/2008, 11:24
H5N1 and Reporters
Perezoso | 18/08/2008, 20:20
The text attributed to Holbrooke and Garrett would be the text in quotes. (?!?)
The argument you make with respect to patents is the same red herring argument that WIPO makes. The problem is not the applicability of patent claim XXX in country YYY, it is that patent claims - mainly in developed countries are resulting in Indonesia and others being ripped off.
This is equally the case if a flu gene or sequence is claimed as a composition of matter, or if it is claimed for use in a particular vaccine or other product. It's really not that difficult a concept, but some people, especially apologists for the patent system, have a hard time wrapping their head around the concept.
I find your post difficult to follow. In particular, I can't decipher which paragraphs or sentences are attributed to Holbrooke and Garrett and which to you.
FYI - the genetic sequences of patent claims are nearly all to very short sequences or to specific vaccine formulations. Many countries do not allow patents on genetic sequences, so the international effect is minimal or non-existant (depending on the country). A report from WIPO on this subject is forthcoming soon.